MONDAY, Oct. 14, 2024 (HealthDay News) — As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might raise psychiatric risks, including the risk for suicide and suicidal thoughts. But a new study involving more than 54,000 U.S. adolescentsContinue Reading
MONDAY, Oct. 14, 2024 (HealthDay News) — Results from a very small study suggest that a combination of the diabetes drug Ozempic and an innovative new intestinal procedure could help erase the need for insulin in folks with type 2 diabetes. The new trial hasn’t yet been published in aContinue Reading
FRIDAY, Oct. 11, 2024 (HealthDay News) — The key to weight loss could come down to a combination of 14 “skinny genes,” a recent study says. People with these genes dropped twice as much weight through regular exercise compared to those without the genes, researchers found. Those with the mostContinue Reading
WEDNESDAY, Oct. 9, 2024 (HealthDay News) — When it comes to coverage for the pricey GLP-1 weight-loss drugs Wegovy and Zepbound, only a fifth of large U.S. companies cover the medications in their health insurance plans, a new survey shows. In a report published Wednesday in the journal Health Affairs,Continue Reading
WEDNESDAY, Oct. 2, 2024 (HealthDay News) — Most Americans are eating their way to inflammation that puts them at risk of cancer, heart disease and other serious health problems, a new study shows. “Overall, 57% of U.S. adults have a pro-inflammatory diet and that number was higher for Black Americans,Continue Reading
TUESDAY, Oct. 1, 2024 (HealthDay News) — Food left in the stomach or stool left in the bowel can impede a doctor’s ability to successfully perform an endoscopy or colonoscopy. Now, research finds this scenario is more likely if the patient is taking popular new weight-loss meds such as Ozempic,Continue Reading
-690x550.jpg)
THURSDAY, Sept. 26, 2024 (HealthDay News) — There’s good news for folks who struggle to fit regular exercise into their busy workweek. “Weekend warrior” workouts are just as beneficial as daily exercise to a person’s overall health, a new study says. People who get all their weekly recommended exercise inContinue Reading
THURSDAY, Sept. 26, 2024 (HealthDay News) — “Body roundness” could be a better measure than BMI at predicting how excess weight might affect a person’s heart health, a new study finds. People who developed a high Body Roundness Index during a six-year period had a 163% increased risk of heartContinue Reading
WEDNESDAY, Sept. 25, 2024 (HealthDay News) — In a finding that suggests Ozempic and Wegovy have powers that extend beyond weight loss, a new study finds the medications might also lower people’s risk of opioid overdose. People with type 2 diabetes prescribed semaglutide (Ozempic, Wegovy) had a significantly lower riskContinue Reading
WEDNESDAY, Sept. 25, 2024 (HealthDay News) — During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced tough questions over the company’s high prices for its blockbuster drugs Ozempic and Wegovy. While testifying before the Senate Committee on Health, Education, Labor and Pensions,Continue Reading